All three cited sources are reachable and support a CHAMPIONED outcome showing genuine leadership. Source 1 (Senate Finance Committee, Dec 4 2025) confirms Crapo, as Finance Committee Chairman, jointly authored and INTRODUCED the PBM Price Transparency and Accountability Act with Ranking Member Wyden — delinking PBM compensation from rebates, increasing PBM reporting to Medicare Part D plan sponsors, and aiming to lower patient costs at the pharmacy counter (sponsored/authored/led, not merely a vote). Source 2 (Senate Finance Committee, Jan 30 2026) verbatim-confirms Crapo's statement that he "successfully included significant reforms from the Committee's pharmacy benefit manager package that will increase transparency in the Medicare Part D program and lower seniors' costs at the pharmacy counter." Source 3 (Mintz, Feb 2026) verbatim-confirms the Consolidated Appropriations Act, 2026 was passed and signed on Feb 3 2026 with PBM reforms governing Medicare Part D. As Chairman authoring the legislation and shepherding its provisions into enacted law, this constitutes real leadership toward the promised goal, well beyond a single vote — CHAMPIONED is upheld. Confidence held at 0.88 (not higher) because the enacted Part D standards phase in beginning plan year 2028, so realized patient savings remain prospective, and the delivered PBM-focused reform is somewhat narrower than "modernizing the prescription drug benefit" broadly.